Our technology is at the forefront of geroscience, the study of cellular and molecular mechanisms of aging that are common to many diseases and chronic conditions. Sapere Bio-funded clinical development is ongoing in heart and vascular and oncology indications. In addition, close collaborations with leading physician scientists lay the foundation for understanding how senescent cell load can be measured and modified to improve clinical outcomes.